Literature DB >> 23812828

Obliterative portal venopathy: a clinical and histopathological review.

Sourabh Aggarwal1, M Isabel Fiel, Thomas D Schiano.   

Abstract

Non-cirrhotic portal hypertension (NCPH) is characterized by the elevation of the portal pressure in the absence of cirrhosis. Obliterative portal venopathy (OPV) as a cause of NCPH is being increasingly diagnosed, especially after recent reports of its occurrence in patients with HIV using didanosine. Patients usually present with episodes of variceal hemorrhage and other features of portal hypertension including jaundice, ascites, encephalopathy and hepatopulmonary syndrome. Hepatic synthetic function is typically well preserved and the laboratory evaluation in OPV patients typically reveals only mild nonspecific hematological abnormalities chiefly related to hypersplenism. Its diagnosis remains a challenge and patients are often mistakenly diagnosed as having cirrhosis. Despite the increasing recognition of OPV, its etiology and pathogenesis are still unclear. A number of etiologies have been proposed including genetic predisposition, recurrent bacterial infections, HIV infection and highly active antiretroviral therapy, an altered immune response, hypercoagulability, and exposure to chemicals and certain medications. Histopathological evaluation remains critical in excluding cirrhosis and other causes of portal hypertension, and is the only way of definitively establishing the diagnosis of OPV. Clinicians should have a high index of suspicion for OPV in patients who present with variceal bleeding and splenomegaly and who do not have other features of cirrhosis. The purpose of this review is to summarize the known etiologies for OPV and its associated clinical aspects and correlations, and to also provide ample histophotomicrographs of OPV to aid in the diagnosis. It will also help raise awareness of this entity amongst pathologists and clinicians alike.

Entities:  

Mesh:

Year:  2013        PMID: 23812828     DOI: 10.1007/s10620-013-2736-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  22 in total

Review 1.  Portal biliopathy.

Authors:  R Chandra; D Kapoor; A Tharakan; A Chaudhary; S K Sarin
Journal:  J Gastroenterol Hepatol       Date:  2001-10       Impact factor: 4.029

2.  Portal hypertension and bleeding esophageal varices; their occurrence in the absence of both intrahepatic and extrahepatic obstruction of the portal vein.

Authors:  W A TISDALE; G KLATSKIN; W W GLENN
Journal:  N Engl J Med       Date:  1959-07-30       Impact factor: 91.245

3.  Portal hypertension and gross splenomegaly in Uganda.

Authors:  H M LEATHER
Journal:  Br Med J       Date:  1961-01-07

Review 4.  Non-cirrhotic portal fibrosis.

Authors:  S K Sarin
Journal:  J Gastroenterol Hepatol       Date:  2002-12       Impact factor: 4.029

5.  The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV.

Authors:  Thomas D Schiano; Alison Uriel; Douglas T Dieterich; M Isabel Fiel
Journal:  Virchows Arch       Date:  2010-11-06       Impact factor: 4.064

6.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 30-1989. A 52-year-old man from India with splenomegaly, esophageal varices, and recurrent gastrointestinal bleeding.

Authors: 
Journal:  N Engl J Med       Date:  1989-07-27       Impact factor: 91.245

7.  Portal vein thrombosis and budd-Chiari syndrome.

Authors:  Paulo Lisboa Bittencourt; Cláudia Alves Couto; Daniel Dias Ribeiro
Journal:  Hematol Oncol Clin North Am       Date:  2011-10       Impact factor: 3.722

8.  Obliterative portal venopathy of the liver. Associated with so-called idiopathic portal hypertension or tropical splenomegaly.

Authors:  N C Nayak; V Ramalingaswami
Journal:  Arch Pathol       Date:  1969-04

Review 9.  Hemodynamic evaluation of the patient with portal hypertension.

Authors:  J Bosch; R Mastai; D Kravetz; M Navasa; J Rodés
Journal:  Semin Liver Dis       Date:  1986-11       Impact factor: 6.115

10.  Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.

Authors:  I W Graziadei; R H Wiesner; P J Marotta; M K Porayko; J E Hay; M R Charlton; J J Poterucha; C B Rosen; G J Gores; N F LaRusso; R A Krom
Journal:  Hepatology       Date:  1999-11       Impact factor: 17.425

View more
  8 in total

1.  Hepatic arterial buffer response: pathologic evidence in non-cirrhotic human liver with extrahepatic portal vein thrombosis.

Authors:  Natalia Rush; Hongliu Sun; Yukihiro Nakanishi; Wadad Mneimneh; Paul Y Kwo; Romil Saxena
Journal:  Mod Pathol       Date:  2016-02-26       Impact factor: 7.842

Review 2.  Pathology of idiopathic non-cirrhotic portal hypertension.

Authors:  Maria Guido; Samantha Sarcognato; Diana Sacchi; Guido Colloredo
Journal:  Virchows Arch       Date:  2018-04-12       Impact factor: 4.064

Review 3.  Multimodality imaging of obliterative portal venopathy: what every radiologist should know.

Authors:  A Arora; S K Sarin
Journal:  Br J Radiol       Date:  2014-12-16       Impact factor: 3.039

Review 4.  Idiopathic Non-Cirrhotic Portal Hypertension and Porto-Sinusoidal Vascular Disease: Review of Current Data.

Authors:  Michel Kmeid; Xiuli Liu; Samuel Ballentine; Hwajeong Lee
Journal:  Gastroenterology Res       Date:  2021-04-21

5.  Living donor liver transplantation for idiopathic portal hypertension with focal nodular hyperplasia.

Authors:  Yoshiaki Tanji; Kenei Furukawa; Yosuke Igarashi; Mitsuru Yanagaki; Koichiro Haruki; Yoshihiro Shirai; Tomohiko Taniai; Takeshi Gocho; Norimitsu Okui; Toru Ikegami
Journal:  Surg Case Rep       Date:  2022-04-21

6.  Porto-Sinusoidal Vascular Disease in a Patient With Diffuse Aortitis and Massive Ascites.

Authors:  Emily Lin; Brian T Lee
Journal:  ACG Case Rep J       Date:  2022-07-06

Review 7.  Idiopathic Noncirrhotic Portal Hypertension: An Appraisal.

Authors:  Hwajeong Lee; Aseeb Ur Rehman; M Isabel Fiel
Journal:  J Pathol Transl Med       Date:  2015-11-11

8.  Histologic Lesions of Porto-Sinusoidal Vascular Disease Following Phlebotomy in Hemochromatosis.

Authors:  Tony El Jabbour; Kelsey E McHugh; Deepa T Patil; Chunlai Zuo; Brandon H Koo; Sungeun Kim; Hwajeong Lee
Journal:  Gastroenterology Res       Date:  2020-02-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.